IRF5 and breast carcinoma: Using the JASPAR algorithm to predict transcription factor binding sites, we detected IRF5 binding motifs within the promoter regions of SLC7A5 and IDO1, suggesting that IRF5 may transcriptionally activate these genes, thereby enhancing tryptophan metabolism in breast cancer cells (Fig. 4D).